New Pair Recommendations for the Development of High-Sensitivity Troponin I Assays

North American Website Available!

It looks like you're accessing our website from North America. We have a dedicated page tailored to your region, offering the most relevant information and services.

If you have an existing eCom account, you can log in to the North American site using your current username and password.

Would you like to visit the North America page?

You can access the page here

If you have any questions, please feel free to contact our support team hytest@hytest.fi

New Pair Recommendations for the Development of High-Sensitivity Troponin I Assays

24.02.2021

Early diagnosis of acute myocardial infarction (AMI) as a life-threatening disorder is important for immediate evidence-based therapy. The cardiac troponin I (cTnI) is a gold standard and diagnostic cornerstone in the clinical assessment of AMI. It offers accurate and rapid AMI rule outs.

HyTest offers new 2+1 and 2+2 cTnI pair recommendations targeted for cTnI assay development. The pairs can be found under Cat.# RC4T21, Cat.# 4T21cc, Cat.# 4TC2 or Cat.# RC4TC2, and Cat.# 4T27cc.

New Pair recommendations for cTnI assay development:

undefined

Our new pair recommendations have high sensitivity, and they correlate well with commercially available cTnI assay (Figure 1) with no cross-reactivity to other cardiac or skeletal isoforms of troponin.

undefined

Figure 1. Correlation of HyTest cardiac troponin I in-house assays and commercially available cTnI assay.